Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Lymph node to primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma.
Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer.
Body image in head and neck cancer patients treated with radiotherapy: the impact of surgical procedures.
Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result.
Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.
Pretreatment 18F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma.
Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy.
Radiation Therapy for Advanced Hepatocellular Carcinoma With Hepatic Hilum Involvement and High Bilirubin Level: Better Survival in Decreased Bilirubin After Radiotherapy.
Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.
Factors Associated With Resilience Among Primary Caregivers of Patients With Advanced Cancer Within the First 6 Months Post?Treatment in Taiwan: A Cross?Sectional Study. �
Development and evaluation of a computerized clinical outcome assessment tool for head and neck cancer patients.
Factors influencing body image in posttreatment oral cavity cancer patients.
The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer.
Impact of physical and psychosocial dysfunction on return to work in survivors of oral cavity cancer.
Impact of a behavior change program and health education on social interactions in survivors of head and neck cancer: Randomized controlled trial.
Pretreatment clinical stage predicts locoregional recurrence in patients with esophageal cancer who achieved a complete clinical response to chemoradiotherapy.
Swallowing ability and its impact on dysphagia-specific health-related QOL in oral cavity cancer patients post-treatment.
Pretreatment lymphocyte count as prognostic factor in patients with head-and-neck cancer.
Treatment outcome in patients with locally advanced gastric cancer receiving adjuvant chemoradiotherapy.
Proton Therapy Reduces Treatment-Related Toxicities for Patients with Nasopharyngeal Cancer: A Case-Match Control Study of Intensity-Modulated Proton Therapy and Intensity-Modulated Photon Therapy.
Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.
Pretreatment 18F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma.
Radiation Therapy for Advanced Hepatocellular Carcinoma With Hepatic Hilum Involvement and High Bilirubin Level: Better Survival in Decreased Bilirubin After Radiotherapy.
